Erik Gustafson

6.0k total citations
10 papers, 377 citations indexed

About

Erik Gustafson is a scholar working on Epidemiology, Oncology and Artificial Intelligence. According to data from OpenAlex, Erik Gustafson has authored 10 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 3 papers in Oncology and 2 papers in Artificial Intelligence. Recurrent topics in Erik Gustafson's work include Cytomegalovirus and herpesvirus research (4 papers), Herpesvirus Infections and Treatments (3 papers) and Viral-associated cancers and disorders (3 papers). Erik Gustafson is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Herpesvirus Infections and Treatments (3 papers) and Viral-associated cancers and disorders (3 papers). Erik Gustafson collaborates with scholars based in United States, Israel and France. Erik Gustafson's co-authors include Joyce D. Fingeroth, David R. Sage, Raymond F. Schinazi, Antoinette Chillemi, Robert W. Finberg, William L. Marshall, Thomas Graf, N.A. Jenkins, Kay Huebner and Christine L. Talarico and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Erik Gustafson

10 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Gustafson United States 7 210 170 87 63 59 10 377
Ossie F. Dyson United States 11 183 0.9× 179 1.1× 81 0.9× 41 0.7× 60 1.0× 15 368
Tsuey-Ying Hsu Taiwan 12 263 1.3× 265 1.6× 112 1.3× 75 1.2× 54 0.9× 19 480
Jiin-Tarng Wang Taiwan 9 190 0.9× 243 1.4× 115 1.3× 114 1.8× 54 0.9× 10 390
Melissa J. Blumenthal South Africa 11 103 0.5× 115 0.7× 77 0.9× 59 0.9× 55 0.9× 21 336
Julianna Stylianou United Kingdom 7 172 0.8× 202 1.2× 64 0.7× 98 1.6× 26 0.4× 9 336
Marcel Pietrek Germany 10 209 1.0× 294 1.7× 91 1.0× 37 0.6× 51 0.9× 10 375
Markus Kalla Germany 7 213 1.0× 337 2.0× 155 1.8× 105 1.7× 88 1.5× 9 517
Mark Bain United Kingdom 11 311 1.5× 276 1.6× 128 1.5× 110 1.7× 42 0.7× 11 537
Ramona Jochmann Germany 11 284 1.4× 204 1.2× 201 2.3× 110 1.7× 46 0.8× 14 500
Marjolein J. G. Hooykaas Netherlands 7 150 0.7× 199 1.2× 249 2.9× 117 1.9× 43 0.7× 9 488

Countries citing papers authored by Erik Gustafson

Since Specialization
Citations

This map shows the geographic impact of Erik Gustafson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Gustafson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Gustafson more than expected).

Fields of papers citing papers by Erik Gustafson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Gustafson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Gustafson. The network helps show where Erik Gustafson may publish in the future.

Co-authorship network of co-authors of Erik Gustafson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Gustafson. A scholar is included among the top collaborators of Erik Gustafson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Gustafson. Erik Gustafson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
3.
Gustafson, Erik, et al.. (2023). High risk HPV testing for cervical cancer screening in a Puerto Rican population. Gynecologic Oncology Reports. 48. 101236–101236. 1 indexed citations
4.
Gustafson, Erik, et al.. (2023). Comparative analysis of onychomycosis in Puerto Rico using molecular and conventional approaches. Journal de Mycologie Médicale. 33(3). 101412–101412. 2 indexed citations
5.
Gustafson, Erik, et al.. (2019). DNA-based detection for onychomycosis correlates better to histopathology than does fungal culture. Dermatology Online Journal. 25(7). 15 indexed citations
6.
Marcellino, Daniel, Daniel Strauss, Erik Gustafson, et al.. (2000). Characterization of an Acyclovir‐Resistant Herpes Simplex Virus Type 2 Strain Isolated from a Premature Neonate. The Journal of Infectious Diseases. 181(4). 1458–1461. 42 indexed citations
7.
Gustafson, Erik, Raymond F. Schinazi, & Joyce D. Fingeroth. (2000). Human Herpesvirus 8 Open Reading Frame 21 Is a Thymidine and Thymidylate Kinase of Narrow Substrate Specificity That Efficiently Phosphorylates Zidovudine but Not Ganciclovir. Journal of Virology. 74(2). 684–692. 69 indexed citations
8.
Marshall, William L., Erik Gustafson, Thomas Graf, et al.. (1999). Epstein-Barr Virus Encodes a Novel Homolog of thebcl-2Oncogene That Inhibits Apoptosis and Associates with Bax and Bak. Journal of Virology. 73(6). 5181–5185. 132 indexed citations
9.
Gustafson, Erik, Antoinette Chillemi, David R. Sage, & Joyce D. Fingeroth. (1998). The Epstein-Barr Virus Thymidine Kinase Does Not Phosphorylate Ganciclovir or Acyclovir and Demonstrates a Narrow Substrate Specificity Compared to the Herpes Simplex Virus Type 1 Thymidine Kinase. Antimicrobial Agents and Chemotherapy. 42(11). 2923–2931. 64 indexed citations
10.
Tsichlis, Philip N., S E Bear, Pedro A. Lazo, et al.. (1990). Activation of multiple genes by provirus integration in the Mlvi-4 locus in T-cell lymphomas induced by Moloney murine leukemia virus. Journal of Virology. 64(5). 2236–2244. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026